Unique business model to boost and accelerate Biopharma
Focusing on the future of Biopharma, Phase2Phase provides niche consulting services focused on CMC biologics (Chemistry, Manufacturing and Controls). The services are provided to a wide variety of customers, ranging from small, virtual companies, to big pharma.
This is the basis of our business and an easy way for you to utilize our competences and networks. Assignments can be both short-term and long-term. With special competence in biologics, we can support you with:
- Production of recombinant proteins
- Monoclonal antibodies
- Sourcing a strategic supplier
- Due diligence
- Handling production peaks
- Construction of facilities
- Tech transfer
Phase2Phase is much more than a traditional consultancy organization. A portion of the proceeds from our consultancy business is reinvested in the life science sector by investing in developing life science companies. We thus offer to assist not only with CMC services, but also with financing and risk sharing.
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic inflammatory diseases. Lipum has a biological anti-inflammatory drug candidate that provides a novel mechanism of action and is therefore assumed to have less adverse effects than current treatments in use.
Athera Biotechnologies AB is a dynamic company with a vision to address the need for improved treatment of vascular disease patients and is now pursuing clinical development with its anti-inflammatory antibody.